Journals / International Journal of Medical Biochemistry / 2022 / Cilt: 5 - Sayı: 1

Comparison of inflammation markers in different severities of COVID-19 disease

Pages
34–43
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Age, ferritin, D-dimer, glucose, ALT, AST, urea, creatinine, CRP, HgA1c, IMG, IMG%, and RDW-SD showed a gradual and significant increase in outpatient, ward, and ICU groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We retrospectively analyzed COVID-19 patients for clinical and hematologic features and tried to define the most appropriate markers to diagnose and predict the severity.
📊
Key Findings & Data:All 4443 patients included were diagnosed with reverse trancription-polymerase chain reaction between January 1 and December 30, 2020.
💡
Conclusion & Impact:Age, ferritin, D-dimer, glucose, ALT, AST, urea, creatinine, CRP, HgA1c, IMG, IMG%, and RDW-SD showed a gradual and significant increase in outpatient, ward, and ICU groups (p
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: We retrospectively analyzed COVID-19 patients for clinical and hematologic features and tried to define the most appropriate markers to diagnose and predict the severity. Methods: This is a retrospective cross-sectional study. All 4443 patients included were diagnosed with reverse trancription-polymerase chain reaction between January 1 and December 30, 2020. We classified patients according to their mode of treatment: outpatient, inpatient in the ward, or inpatients in the intensive care unit (ICU). Results: The mean age of 2283 (51.4%) women and 2160 (48.6%) men included in the study was determined to be 39.77±17.30. Of the 4443 patients, 3985 (89.7%) were outpatients, 330 (7.4%) were inpatients, and 128 (2.9%) patients were treated in the ICU. The mean hospital stay was 8.36±4.55 days for the survivors in the ward group and 2.67±1.53 days for those who died (p=0.031). The mean hospitalization time of the survivors in the ICU group was 19.97±12.09 days, and the mean hospitalization time of the deceased was 13.10±9.99 days (p=0.001). Age, ferritin, D-dimer, glucose, ALT, AST, urea, creatinine, CRP, HgA1c, IMG, IMG%, and RDW-SD showed a gradual and significant increase in outpatient, ward, and ICU groups (p

🔖

Cite This Article

KATAR, M., DEMİR, O., YİĞİT, T., ÇİTİL, R., ÖNDER, Y. (2022). Comparison of inflammation markers in different severities of COVID-19 disease. International Journal of Medical Biochemistry, Cilt: 5 - Sayı: 1, 34–43. https://ajindex.com/articles/541399

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med 2020;8(9):593
  2. Lin Y, Ji C, Weng W, Xu P, Hu Y, Liang W, et al. Epidemiological and clinical characteristics of 124 elderly outpatients with COVID-19 in Wuhan,China.Availableat:https://www.semanticscholar.org/paper/Epidemiological-and-Clinical-Characteristics-of124-Lin-Ji/f787f7ef53f921f89f228bedbfdea1cd744c26b0. Accessed Dec 28, 2021
  3. Aktoz M, Altay H, Aslanger E, Atalar E, Atar İ, Aytekin V, et al. Turkish Cardiology Association Consensus Report: COVID-19 pandemic and cardiovascular diseases (May 13, 2020). Turk Kardiyol Dern Ars 2020;48(Suppl 1):1–87
  4. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475–81
  5. Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract 2020;164:108214
  6. Tezcan ME, Dogan Gokce G, Sen N, Zorlutuna Kaymak N, Ozer RS. Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients. New Microbes New Infect 2020;37:100753
  7. Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem 2020;57(3):262–5
  8. Osman W, Al Fahdi F, Al Salmi I, Al Khalili H, Gokhale A, Khamis F. Serum Calcium and Vitamin D levels: Correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman. Int J Infect Dis 2021;107:153–63
  9. Gan Q, Gong B, Sun M, Cao Z, Zheng Y, Zhang Y, et al. A high percentage of patients recovered from COVID-19 but discharged with abnormal liver function tests. Front Physiol 2021;12:642922
  10. Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 2005;67(2):698–705
  11. Cha RH, Joh JS, Jeong I, Lee JY, Shin HS, Kim G, et al; Critical Care Team of National Medical Center. Renal complications and their prognosis in Korean patients with middle east respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci 2015;30(12):1807–14
  12. Na KR, Kim HR, Ham Y, Choi DE, Lee KW, Moon JY,